Notch and T cell malignancy

Seminars in Cancer Biology

Volumn 14, Issue 5, 2004, Pages 329-340

  Zweidler McKay, Patrick A ^a,b   Pear, Warren S ^b,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CSL; Development; Hematopoiesis; Leukemia; Oncogene

Indexed keywords

CYCLINE; NOTCH RECEPTOR;

APOPTOSIS; CELL CYCLE; CELL MATURATION; HEMATOPOIESIS; HUMAN; MUTAGENESIS; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR CELL;

EID: 3342927881     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2004.04.012     Document Type: Article

References (92)

1. Artavanis-Tsakonas S., Matsuno K., Fortini M.E. Notch signaling. Science. 268:1995;225-232
2. Greenwald I. LIN-12/Notch signaling: lessons from worms and flies. Genes Dev. 12:1998;1751-1762
3. Ellisen L.W., Bird J., West D.C., Soreng A.L., Reynolds T.C., Smith S.D., et al. TAN-1, the human homolog of the Drosophila notch gene is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 66:1991;649-661
4. Smith S.D., Morgan R., Gemmill R., Amylon M.D., Lind M.P., Linker C., et al. Clinical and biological characterization of T cell neoplasias with rearrangements of chromosome 7 band q34. Blood. 71:1988;395-402
5. Ma S.K., Wan T.S., Chan L.C. Cytogenetics and molecular genetics of childhood leukemia. Hematol. Oncol. 17:1999;91-105
6. Chiaramonte R., Calzavara E., Balordi F., Sabbadini M., Capello D., Gaidano G., et al. Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture. J. Cell Biochem. 88:2003;569-577
7. Barolo S., Walker R.G., Polyanovsky A.D., Freschi G., Keil T., Posakony J.W. A notch-independent activity of suppressor of hairless is required for normal mechanoreceptor physiology. Cell. 103:2000;957-969
8. Jundt F., Anagnostopoulos I., Forster R., Mathas S., Stein H., Dorken B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 99:2002;3398-3403
9. Bellavia D., Campese A.F., Checquolo S., Balestri A., Biondi A., Cazzaniga G., et al. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3788-3793
10. Ferrando A.A., Look A.T. Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin. Hematol. 40:2003;274-280
11. Maillard I., Adler S.H., Pear W.S. Notch and the immune system. Immunity. 19:2003;781-791
12. Radtke F., Wilson A., Mancini S.J., MacDonald H.R. Notch regulation of lymphocyte development and function. Nat. Immunol. 5:2004;247-253
13. Pear W.S., Aster J.C., Scott M.L., Hasserjian R.P., Soffer B., Sklar J., et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183:1996;2283-2291
14. Pui J.C., Allman D., Xu L., DeRocco S., Karnell F.G., Bakkour S., et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 11:1999;299-308
15. Wilson A., MacDonald H.R., Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194:2001;1003-1012
16. Han H., Tanigaki K., Yamamoto N., Kuroda K., Yoshimoto M., Nakahata T., et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14:2002;637-645
17. Saito T., Chiba S., Ichikawa M., Kunisato A., Asai T., Shimizu K., et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 18:2003;675-685
18. Krebs L.T., Xue Y., Norton C.R., Sundberg J.P., Beatus P., Lendahl U., et al. Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis. 37:2003;139-143
19. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14:2000;1343-1352
20. Hasserjian R.P., Aster J.C., Davi F., Weinberg D.S., Sklar J. Modulated expression of notch1 during thymocyte development. Blood. 88:1996;970-976
21. Reizis B., Leder P. Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev. 16:2002;295-300
22. Wolfer A., Wilson A., Nemir M., MacDonald H.R., Radtke F. Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta lineage thymocytes. Immunity. 16:2002;869-879
23. Deftos M.L., Huang E., Ojala E.W., Forbush K.A., Bevan M.J. Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity. 13:2000;73-84
24. Wong K.K., Carpenter M.J., Young L.L., Walker S.J., McKenzie G., Rust A.J., et al. Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism. J. Clin. Invest. 112:2003;1741-1750
25. Yvon ES, Vigouroux S, Rousseau RF, Biagi E, Amrolia P, Dotti G, et al. Over expression of the Notch ligand, Jagged-1 induces alloantigen-specific human regulatory T cells. Blood 2003;1028:3815-21.
26. Adler S.H., Chiffoleau E., Xu L., Dalton N.M., Burg J.M., Wells A.D., et al. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J. Immunol. 171:2003;2896-2903
27. Hoyne G.F., Le Roux I., Corsin-Jimenez M., Tan K., Dunne J., Forsyth L.M., et al. Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. Int. Immunol. 12:2000;177-185
28. Palaga T., Miele L., Golde T.E., Osborne B.A. TCR-mediated notch signaling regulates proliferation and IFN-gamma production in peripheral T cells. J. Immunol. 171:2003;3019-3024
29. Aster J.C., Xu L., Karnell F.G., Patriub V., Pui J.C., Pear W.S. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1. Mol. Cell. Biol. 20:2000;7505-7515
30. Allman D., Karnell F.G., Punt J.A., Bakkour S., Xu L., Myung P., et al. Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J. Exp. Med. 194:2001;99-106
31. Izon D.J., Punt J.A., Xu L., Karnell F.G., Allman D., Myung P.S., et al. Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. Immunity. 14:2001;253-264
32. Weng A.P., Nam Y., Wolfe M.S., Pear W.S., Griffin J.D., Blacklow S.C., et al. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol. Cell. Biol. 23:2003;655-664
33. Ciofani M, Schmitt TM, Ciofani A, Michie AM, Cuburu N, Aublin A, et al. Obligatory role for cooperative signaling by pre-T cell receptor and Notch during thymocyte differentiation. J Immunol 2004;172:5230-9.
34. Robey E., Chang D., Itano A., Cado D., Alexander H., Lans D., et al. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell. 87:1996;483-492
35. Beverly L.J., Capobianco A.J. Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis. Cancer Cell. 3:2003;551-564
36. Fowlkes B.J., Robey E.A. A reassessment of the effect of activated Notch1 on CD4 and CD8 T cell development. J. Immunol. 169:2002;1817-1821
37. Tsuji H., Ishii-Ohba H., Ukai H., Katsube T., Ogiu T. Radiation-induced deletions in the 5′ end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas. Carcinogenesis. 24:2003;1257-1268
38. Bellavia D., Campese A.F., Alesse E., Vacca A., Felli M.P., Balestri A., et al. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J. 19:2000;3337-3348
39. Rohn J.L., Lauring A.S., Linenberger M.L., Overbaugh J. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma. J. Virol. 70:1996;8071-8080
40. Witt C.M., Hurez V., Swindle C.S., Hamada Y., Klug C.A. Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells. Mol. Cell. Biol. 23:2003;8637-8650
41. Deftos M.L., He Y.W., Ojala E.W., Bevan M.J. Correlating notch signaling with thymocyte maturation. Immunity. 9:1998;777-786
42. Nam Y., Weng A.P., Aster J.C., Blacklow S.C. Structural requirements for assembly of the CSL.intracellular Notch1.Mastermind-like 1 transcriptional activation complex. J. Biol. Chem. 278:2003;21232-21239
43. Kurooka H., Kuroda K., Honjo T. Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region. Nucleic Acids Res. 26:1998;5448-5455
44. Lieber T., Kidd S., Alcamo E., Corbin V., Young M.W. Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei. Genes Dev. 7:1993;1949-1965
45. Jeffries S., Robbins D.J., Capobianco A.J. Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line. Mol. Cell. Biol. 22:2002;3927-3941
46. Wu L., Sun T., Kobayashi K., Gao P., Griffin J.D. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol. Cell. Biol. 22:2002;7688-7700
47. Yan X.Q., Sarmiento U., Sun Y., Huang G., Guo J., Juan T., et al. A novel Notch ligand Dll4 induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer. Blood. 98:2001;3793-3799
48. Dorsch M., Zheng G., Yowe D., Rao P., Wang Y., Shen Q., et al. Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease. Blood. 100:2002;2046-2055
49. Davis R.L., Turner D.L. Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene. 20:2001;8342-8357
50. Kaneta M., Osawa M., Sudo K., Nakauchi H., Farr A.G., Takahama Y. A role for pref-1 and HES-1 in thymocyte development. J. Immunol. 164:2000;256-264
51. Tomita K., Hattori M., Nakamura E., Nakanishi S., Minato N., Kageyama R. The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev. 13:1999;1203-1210
52. Kawamata S., Du C., Li K., Lavau C. Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene. 21:2002;3855-3863
53. Izon D.J., Aster J.C., He Y., Weng A., Karnell F.G., Patriub V., et al. Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity. 16:2002;231-243
54. Lacorazza H.D., Porritt H.E., Nikolich-Zugich J. Dysregulated expression of pre-Talpha reveals the opposite effects of pre-TCR at successive stages of T cell development. J. Immunol. 167:2001;5689-5696
55. Bain G., Engel I., Robanus Maandag E.C., te Riele H.P., Voland J.R., Sharp L.L., et al. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:1997;4782-4791
56. Rabbitts T.H. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev. 12:1998;2651-2657
57. Sasai Y., Kageyama R., Tagawa Y., Shigemoto R., Nakanishi S. Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev. 6:1992;2620-2634
58. Ordentlich P., Lin A., Shen C.P., Blaumueller C., Matsuno K., Artavanis-Tsakonas S., et al. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18:1998;2230-2239
59. Nie L., Xu M., Vladimirova A., Sun X.H. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J. 22:2003;5780-5792
60. Talora C., Campese A.F., Bellavia D., Pascucci M., Checquolo S., Groppioni M., et al. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep. 4:2003;1067-1071
61. Carrasco D., Rizzo C.A., Dorfman K., Bravo R. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice. EMBO J. 15:1996;3640-3650
62. Cheng P., Zlobin A., Volgina V., Gottipati S., Osborne B., Simel E.J., et al. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J. Immunol. 167:2001;4458-4467
63. Oswald F., Liptay S., Adler G., Schmid R.M. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol. Cell. Biol. 18:1998;2077-2088
64. Wang J., Shelly L., Miele L., Boykins R., Norcross M.A., Guan E. Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. J. Immunol. 167:2001;289-295
65. Bash J., Zong W.X., Banga S., Rivera A., Ballard D.W., Ron Y., et al. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J. 18:1999;2803-2811
66. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 49:1989;4682-4689
67. Weijzen S., Rizzo P., Braid M., Vaishnav R., Jonkheer S.M., Zlobin A., et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat. Med. 8:2002;979-986
68. Donnellan R., Chetty R. Cyclin D1 and human neoplasia. Mol. Pathol. 51:1998;1-7
69. Ronchini C., Capobianco A.J. Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol. Cell. Biol. 21:2001;5925-5934
70. Sicinska E., Aifantis I., Le Cam L., Swat W., Borowski C., Yu Q., et al. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell. 4:2003;451-461
71. He Y.W. Orphan nuclear receptors in T lymphocyte development. J. Leukoc. Biol. 72:2002;440-446
72. Jehn B.M., Bielke W., Pear W.S., Osborne B.A. Protective effects of notch-1 on TCR-induced apoptosis. J. Immunol. 162:1999;635-638
73. Sade H, Krishna S, Sarin A. The anti-apoptotic effect of notch-1 requires p56lck-dependent, Akt/PKB-mediated signalling in T cells. J Biol Chem 2003;279:2937-44.
74. Feldman B.J., Hampton T., Cleary M.L. A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice. Blood. 96:2000;1906-9013
75. Rebay I., Fehon R.G., Artavanis-Tsakonas S. Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor. Cell. 74:1993;319-329
76. Mango S.E., Maine E.M., Kimble J. Carboxy-terminal truncation activates glp-1 protein to specify vulval fates in Caenorhabditis elegans. Nature. 352:1991;811-815
77. Axelrod J.D., Matsuno K., Artavanis-Tsakonas S., Perrimon N. Interaction between Wingless and Notch signaling pathways mediated by dishevelled. Science. 271:1996;1826-1832
78. Cobas M., Wilson A., Ernst B., Mancini S.J., MacDonald H.R., Kemler R., et al. {Beta}-catenin is dispensable for hematopoiesis and lymphopoiesis. J. Exp. Med. 199:2004;221-229
79. Girard L., Hanna Z., Beaulieu N., Hoemann C.D., Simard C., Kozak C.A., et al. Frequent proviral insertional mutagenesis of NOTCH1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and NOTCH1 for oncogenesis. Genes Dev. 10:1996;1930-1944
80. Hoemann C.D., Beaulieu N., Girard L., Rebai N., Jolicoeur P. Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice. Mol. Cell. Biol. 20:2000;3831-3842
81. Lauring A.S., Overbaugh J. Evidence that an IRES within the Notch2 coding region can direct expression of a nuclear form of the protein. Mol. Cell. 6:2000;939-945
82. Fujii K., Ishimaru F., Nakase K., Tabayashi T., Kozuka T., Naoki K., et al. Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma. Br. J. Haematol. 120:2003;986-989
83. Sun L., Goodman P.A., Wood C.M., Crotty M.L., Sensel M., Sather H., et al. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 17:1999;3753-3766
84. Kang-Decker N., Tong C., Boussouar F., Baker D.J., Xu W., Leontovich A.A., et al. Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell. 5:2004;177-189
85. Akagi K., Suzuki T., Stephens R.M., Jenkins N.A., Copeland N.G. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32:2004;D523-D527
86. Seiffert D., Bradley J.D., Rominger C.M., Rominger D.H., Yang F., Meredith J.E. Jr., et al. Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J. Biol. Chem. 275:2000;34086-34091
87. Hadland B.K., Manley N.R., Su D., Longmore G.D., Moore C.L., Wolfe M.S., et al. Gamma-secretase inhibitors repress thymocyte development. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7487-7491
88. Fortini M.E. Gamma-secretase-mediated proteolysis in cell-surface- receptor signalling. Nat. Rev. Mol. Cell. Biol. 3:2002;673-684
89. Micchelli C.A., Esler W.P., Kimberly W.T., Jack C., Berezovska O., Kornilova A., et al. Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila. FASEB J. 17:2003;79-81
90. Wong G.T., Manfra D., Poulet F.M., Zhang Q., Josien H., Bara T., et al. Chronic treatment with the {gamma}-secretase inhibitor LY-411,575 inhibits {beta}-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem. 279:2004;12876-12882
91. Dewachter I., Van Leuven F. Secretases as targets for the treatment of Alzheimer's disease: the prospects. Lancet Neurol. 1:2002;409-416
92. Deguchi K., Gilliland D.G. Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML. Leukemia. 16:2002;740-744